249 related articles for article (PubMed ID: 2552329)
1. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
Mülsch A; Lückhoff A; Pohl U; Busse R; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):119-25. PubMed ID: 2552329
[TBL] [Abstract][Full Text] [Related]
2. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
[TBL] [Abstract][Full Text] [Related]
3. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit.
Kawada T; Ishibashi T; Sasage H; Kato K; Imai S
Gen Pharmacol; 1994 Nov; 25(7):1361-71. PubMed ID: 7896047
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived relaxant factor inhibits platelet activation.
Busse R; Lückhoff A; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):566-71. PubMed ID: 2830546
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.
Rapoport RM; Murad F
Eur J Pharmacol; 1984 Sep; 104(1-2):61-70. PubMed ID: 6149944
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
7. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
Mülsch A; Busse R; Liebau S; Förstermann U
J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
[TBL] [Abstract][Full Text] [Related]
8. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
Salvemini D; Radziszewski W; Korbut R; Vane J
Br J Pharmacol; 1990 Dec; 101(4):991-5. PubMed ID: 1707709
[TBL] [Abstract][Full Text] [Related]
9. Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester.
Smith JA; Lang D
Br J Pharmacol; 1990 Mar; 99(3):565-71. PubMed ID: 1691949
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin.
Bennett BM; McDonald BJ; Nigam R; Long PG; Simon WC
Can J Physiol Pharmacol; 1992 Sep; 70(9):1297-303. PubMed ID: 1362924
[TBL] [Abstract][Full Text] [Related]
11. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular smooth muscle relaxation by LY83583.
Malta E; Macdonald PS; Dusting GJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):459-64. PubMed ID: 2900475
[TBL] [Abstract][Full Text] [Related]
13. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
14. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
Bassenge E
Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
[TBL] [Abstract][Full Text] [Related]
16. Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta.
Rapoport RM; Murad F
Gen Pharmacol; 1988; 19(1):61-5. PubMed ID: 2894333
[TBL] [Abstract][Full Text] [Related]
17. Nitrovasodilators and cGMP inhibit human platelet activation.
Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
[TBL] [Abstract][Full Text] [Related]
18. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC; Challiss RA; Boyle JP
Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
